Clin2
NCT06685978Possibly a fitRecruiting

Study of Xiangjurupining Capsule for Breast Lumps and Pain

Hyperplasia of Mammary Glands

Part of Women’s health & pregnancy clinical trials.

This trial tests a Chinese herbal capsule (Xiangjurupining) for women with breast hyperplasia (non-cancerous breast lumps and pain). It aims to see if the capsule can safely reduce pain and improve symptoms over several menstrual cycles.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
430 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • You are a woman aged 18 to 50
  • You have had breast lumps and pain for at least 3 months, diagnosed as breast hyperplasia
  • Your breast pain is moderate to severe (score 4 or higher on a 0–10 scale) on most days of your menstrual cycle
  • Your breast ultrasound shows a low-risk finding (BI-RADS 1–3) without suspicious changes
  • You are not pregnant, breastfeeding, or planning pregnancy in the next 6 months
  • You have not used hormonal treatments (like birth control pills) in the last 6 months or other breast pain treatments in the last month

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05772104Recruiting· Phase 3
Test a Chinese herbal capsule for generalized anxiety

This Phase 3 trial studies Shugan Jieyu Capsule to treat generalized anxiety disorder (GAD). It aims to see if it can reduce anxiety symptoms in people who fit specific anxiety severity and traditional diagnosis criteria.

Beijing
NCT06696261Recruiting· Phase 3
Lianxiaxiaopi granules for post-meal fullness

This study tests a Chinese herbal granule (Lianxiaxiaopi) for people with postprandial distress syndrome, a condition where you feel full too soon or uncomfortably full after eating. The goal is to see if it helps reduce these symptoms.

Beijing, Beijing Municipality
NCT07512648Not yet recruiting
Chinese herbal treatment for non-lactational breast lumps

This trial tests a traditional Chinese herbal medicine (Sanyong Jiedu Granules) to treat non-lactational mastitis—a breast condition involving lumps and inflammation not related to breastfeeding. The study aims to see if this herbal treatment safely reduces these lumps.

Shenyang, Liaoning
NCT06727890Not yet recruiting· Phase 4
Study of a Chinese herbal pill for diabetes-related chest pain

This trial tests if a traditional Chinese medicine called Compound Danshen Dripping Pill can help people with type 2 diabetes who have chest pain even though their heart arteries look normal or only mildly narrowed. The goal is to see if it improves blood flow in small heart vessels.

Jinan, Shandong
NCT06881550Enrolling by invitation
Herbal medicine study for women after breast cancer surgery

This trial tests whether a Chinese herbal medicine (Shenbailing granules) can help improve energy and blood health in women recovering from breast cancer surgery.

Shenyang, Chian/Liaoning
NCT06381557Not yet recruiting· Phase 4
Zhengyuan capsules for fatigue in breast cancer survivors

This trial tests a traditional Chinese medicine, Zhengyuan Capsules, to see if it helps reduce cancer-related fatigue in breast cancer survivors. You may qualify if your fatigue is moderate to severe and you have finished your main treatments at least two months ago.

Hear when a new Hyperplasia of Mammary Glands trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.